Get 50% OFF This Monsoon!
Gayatri BioOrganics
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Incorporated on December 02, 1991 and promoted jointly by T V Sandeep Reddy and D S P Reddy and Associates, Gayatri BioOrganics Limited (Formerly known Gayatri Starchkem Ltd), is one of the largest manufacturing units of Starch, Modified Starches ,Liquid Glucose, Sorbitol, and its allied products in south India with a wide distribution network across the country. It is mainly in the business of manufacturing of Starch, its derivatives and related by-products, and development of customised application for value added starch derivatives. The Company has manufacturing plants located in states of Karnataka and Telangana. It is engaged in the manufacture of sorbitol with an installed capacity of 8550 tpa.
The Company has a technical collaboration with Lurgi Oil Gas Chemie, Germany, for transfer of know-how, to manufacture sorbitol by adopting state-of-the-art low-pressure hydrogenation technology. Sorbitol is used in tonic/liquid formulations, toothpastes, cosmetic products like face creams and lotions, in tobacco processing for cigarettes, and in the paint, leather, paper, textile and food industries, etc. Sorbitol is more immune to bacteriological degradation than sugar, and is less vulnerable to mould growths than most other humectants and plasticising materials.
The company came out with a public issue in Apr.'94 to part-finance a project to manufacture 8550 tpa of sorbitol. At Gayatri Bio-organics Limited, the state of art technology adopted from Lurgi Ol. Gas. Chemie GMBH, Germany (LURGI), LURGI are well known for their Sorbitol processors in low pressure hydrogenation technology. They have substantial and experience and expertise in Sorbitol manufacturing and have built several plants all over world, for several industries including chemical and metallurgical projects.
To achieve economies of scale in the manufacture of sorbitol, reduce raw material cost and improve quality, the company has embarked by setting up a starch project, as a backward integration project to the existing sorbitol plant with a rated capacity of 150 tpd at a capital cost of Rs 27 cr. The trial production has commenced on June, 1998 and commercial production of strach powder was commenced since august 1998 after installation of balance equipments by the end of July, 1998.
The company is also in process of implementing ISO 9002 standards for Starch division. Since net worth has been fully eroded the company was referred to BIFR and the Board appointed IDBI as Operating Agency.
Gayatri BioOrganics share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Gayatri BioOrganics indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Gayatri BioOrganics is valued compared to its competitors.
Gayatri BioOrganics PE ratio helps investors understand what is the market value of each stock compared to Gayatri BioOrganics 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Gayatri BioOrganics evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Gayatri BioOrganics generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Gayatri BioOrganics in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Gayatri BioOrganics shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Gayatri BioOrganics compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Gayatri BioOrganics over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Gayatri BioOrganics helps investors get an insight into when they can enter or exit the stock. Key components of Gayatri BioOrganics Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Gayatri BioOrganics shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Gayatri BioOrganics ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Gayatri BioOrganics provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Gayatri BioOrganics highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Gayatri BioOrganics .
The balance sheet presents a snapshot of Gayatri BioOrganics ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.